1. |
Stephan S, Datta K, Wang E, et al. Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer [J]. Clin Cancer Res, 2004; 10(20)∶6993.
|
2. |
Boffa DJ, Luan F, Thomas D, et al. Rapamycin inhibits the gr-owth and metastatic progression of non-small cell lung cancer [J]. Clin Cancer Res, 2004; 10(1 Pt 1)∶293.
|
3. |
Granger DK, Cromwell JW, Chen SC, et al. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy [J]. Transplantation, 1995; 59(2)∶183.
|
4. |
Kreis H, Cisterne JM, Land W, et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients [J]. Transplantation, 2000; 69(7)∶1252.
|
5. |
Wiedmann MW, Caca K. Molecularly targeted therapy for gastrointestinal cancer [J].Curr Cancer Drug Targets, 2005; 5(3)∶171.
|
6. |
Rathmell WK, Wright TM, Rini BI. Molecularly targeted therapy in renal cell carcinoma [J]. Expert Rev Anticancer Ther, 2005; 5(6)∶1031.
|
7. |
Newmeyer DD, Farschon DM, Reed JC. Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria [J].Cell, 1994; 79(2)∶353.
|
8. |
Alano CC, Beutner G, Dirksen RT, et al. Mitochondrial permeability transition and calcium dynamics in striatal neurons upon intense NMDA receptor activation [J]. J Neurochem, 2002; 80(3)∶531.
|
9. |
Hengartner MO. The biochemistry of apoptosis [J]. Nature, 2000; 407(6805)∶770.
|